A new daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the FDA approval of Novo Nordisk’s Wegovy pill.
A new daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the FDA approval of Novo Nordisk’s Wegovy pill.